Novo Nordisk Pharma AG
Novo Nordisk Pharma AG is a Originators company based in Zürich (Zurich) recorded by Swissmedic as the authorisation holder for 36 human medicines. That places it 44 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Biotechnologika.
Key facts
| Sector | Originators |
|---|---|
| City | Zürich |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 36 |
| Founded | Not available |
| Employees | 51-200 |
| Parent group | Novo Nordisk A/S |
| Activity | Not available |
| Website | novonordisk.ch |
Medicines authorised in Switzerland
Novo Nordisk Pharma AG is recorded by Swissmedic as the authorisation holder for 36 human medicines. The table shows 36 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
36 of 36 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Activelle | 54708 | B | G03FA01 | 1998-12-15 |
| Actrapid HM | 44610 | B | A10AB01 | 1986-08-22 |
| Alhemo 15 mg/1.5 ml | 68844 | A | B02BX | 2023-08-08 |
| Awiqli FlexTouch 700 E/ml | 69389 | B | A10AE | 2024-03-07 |
| Esperoct 500 IE | 67156 | B | B02BD02 | 2019-07-30 |
| Estrofem 1 mg N | 40050 | B | G03CA03 | 1977-05-17 |
| Fiasp 100 E/ml ultra-fast-acting PumpCart | 67809 | B | A10AB05 | 2021-02-18 |
| Fiasp ultra-fast-acting | 66202 | B | A10AB05 | 2017-06-07 |
| Fiasp ultra-fast-acting FlexTouch | 66200 | B | A10AB05 | 2017-06-07 |
| Fiasp ultra-fast-acting Penfill | 66201 | B | A10AB05 | 2017-06-07 |
| GlucaGen Novo | 31489 | B | H04AA01 | 1965-05-06 |
| Insulatard HM | 45495 | B | A10AC01 | 1986-08-22 |
| Insulin NovoNordisk Levemir 100 E/ml FlexPen | 56371 | B | A10AE05 | 2003-11-10 |
| Insulin NovoNordisk Levemir 100 E/ml Penfill | 56370 | B | A10AE05 | 2003-11-10 |
| Insulin NovoNordisk NovoRapid | 55045 | B | A10AB05 | 1999-06-15 |
| Insulin NovoNordisk NovoRapid FlexPen | 55712 | B | A10AB05 | 2000-12-08 |
| Insulin NovoNordisk NovoRapid Penfill | 55046 | B | A10AB05 | 1999-06-15 |
| Insulin NovoNordisk NovoRapid PumpCart 100 E/ml | 65630 | B | A10AB05 | 2016-02-01 |
| Kliogest N | 47526 | B | G03FA01 | 1986-11-14 |
| Norditropin FlexPro 5 mg | 60469 | A | H01AC01 | 2010-06-18 |
| Novofem | 56184 | B | G03FB05 | 2003-12-08 |
| NovoSeven 1 mg | 58693 | B | B02BD08 | 2009-03-27 |
| Ozempic DualDose 0.25 mg / 0.5 mg | 66604 | B | A10BJ06 | 2018-07-02 |
| Refixia 500 IE | 66216 | B | B02BD04 | 2017-09-05 |
| Rybelsus N 1.5 mg | 69865 | B | A10BJ06 | 2025-11-28 |
| Ryzodeg FlexTouch | 62648 | B | A10AD06 | 2013-09-12 |
| Ryzodeg Penfill | 62627 | B | A10AD06 | 2013-09-12 |
| Sogroya 5 mg/ 1.5 ml | 69063 | A | H01AC07 | 2024-04-26 |
| Tresiba FlexTouch 100 E/ml | 62563 | B | A10AE06 | 2013-03-12 |
| Tresiba Penfill | 62562 | B | A10AE06 | 2013-03-12 |
| Trisequens N | 40051 | B | G03FB05 | 1977-05-17 |
| Vagifem 10 µg | 49600 | B | G03CA03 | 1988-06-20 |
| Victoza 6 mg/ml | 59329 | B | A10BJ02 | 2009-12-11 |
| Wegovy FixDose 0.25 mg | 68238 | B | - | 2022-02-15 |
| Wegovy Multi FixDose 0.25 mg | 68798 | B | A10BJ06 | 2023-03-20 |
| Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml | 65041 | B | A10AE56 | 2014-09-12 |
Frequently asked questions
How many medicines does Novo Nordisk Pharma AG have authorised in Switzerland?
Novo Nordisk Pharma AG is recorded by Swissmedic as the authorisation holder for 36 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Novo Nordisk Pharma AG based?
The Swiss location recorded for Novo Nordisk Pharma AG is Zürich, Zurich.
Is Novo Nordisk Pharma AG a Swissmedic authorisation holder?
Yes. Novo Nordisk Pharma AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.